Search results
Critical Mass with Law.com’s Amanda Bronstad: Roundup Trial Revs Up in Missouri, $100M Fee Award in...
Law.com· 3 days agoThis week: A trial involving three plaintiffs who sprayed Monsanto’s Roundup began this week in St....
Myelofibrosis: A Rare Malignancy Attracting More and More Attention
MedPage Today· 3 days agoMyelofibrosis remains a rare disease, even though recent attention to the condition might suggest...
Glecirasib Shows Promising Efficacy in KRAS-Mutated NSCLC
MedPage Today· 3 days agoTrend towards better response rate, PFS compared with approved KRAS inhibitors
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management
MedPage Today· 3 days agoThe history of primary myelofibrosis dates back to 1951 and the description of four distinct...
Major European Markets Close Lower On Rate Uncertainty, Growth Concerns
RTT News· 1 day agoThe major European markets closed lower on Thursday as investors reacted to corporate earnings updates, and the Federal Reserve's monetary policy announcement that indicated interest rate in the U.
10 of the Best Fund Managers Focused on Large-Cap Stocks
Morningstar· 2 days agoIn an effort to find new stock picks for investors to research further, we often turn to the portfolio holdings of top concentrated fund managers. By our definition, the best fund managers running ...
After 'reset,' Flagship startup lands $1.8B Bristol Myers Squibb deal - Boston Business Journal
The Business Journals· 5 days agoTorben Straight Nissen took over the reins of Repertoire Immune Medicines at the tail end of 2022,...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 22 hours agoBrooklyn, New York, May 03, 2024 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the global biomaterial-based vaccines market is analyzed to grow at a CAGR of 17.7% during the forecast period
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoInnovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO) PR Newswire SAN FRANCISCO and SUZHOU, China, April 30, 2024 SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("
